[go: up one dir, main page]

MXPA05006688A - Conjugados de polimero con una variante de cianovirina. - Google Patents

Conjugados de polimero con una variante de cianovirina.

Info

Publication number
MXPA05006688A
MXPA05006688A MXPA05006688A MXPA05006688A MXPA05006688A MX PA05006688 A MXPA05006688 A MX PA05006688A MX PA05006688 A MXPA05006688 A MX PA05006688A MX PA05006688 A MXPA05006688 A MX PA05006688A MX PA05006688 A MXPA05006688 A MX PA05006688A
Authority
MX
Mexico
Prior art keywords
cyanovirin
polymer conjugates
conjugates
variant
cyanovirin variant
Prior art date
Application number
MXPA05006688A
Other languages
English (en)
Inventor
Michael R Boyd
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Publication of MXPA05006688A publication Critical patent/MXPA05006688A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)

Abstract

La presente invencion proporciona variantes de cianovirina-N y polimeros solubles en agua, en particular conjugados PEGilados de los mismos. La cianovirina-N de la invencion esta particularmente adaptada para fijacion covalente selectiva puntual de uno o mas polimeros solubles en agua, para proporcionar conjugados polimericos de variantes de cianovirina-N que exhiben actividad anti-viral.
MXPA05006688A 2002-12-19 2003-12-18 Conjugados de polimero con una variante de cianovirina. MXPA05006688A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43595002P 2002-12-19 2002-12-19
US46173103P 2003-04-09 2003-04-09
PCT/US2003/040585 WO2004056852A2 (en) 2002-12-19 2003-12-18 Cyanovirin variant-polymer conjugates

Publications (1)

Publication Number Publication Date
MXPA05006688A true MXPA05006688A (es) 2006-02-22

Family

ID=32685420

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006688A MXPA05006688A (es) 2002-12-19 2003-12-18 Conjugados de polimero con una variante de cianovirina.

Country Status (10)

Country Link
US (2) US7267941B2 (es)
EP (1) EP1620129B1 (es)
JP (2) JP2006517400A (es)
KR (1) KR101145990B1 (es)
AT (1) ATE425767T1 (es)
AU (1) AU2003301122B2 (es)
CA (1) CA2507904C (es)
DE (1) DE60326774D1 (es)
MX (1) MXPA05006688A (es)
WO (1) WO2004056852A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7267941B2 (en) * 2002-12-19 2007-09-11 The Government of the United States of America as represented by The Secretary of The Department of Health and Human Services, The National Institutes of Health Cyanovirin variant-polymer conjugates
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
WO2007037245A1 (ja) * 2005-09-29 2007-04-05 Shionogi & Co., Ltd. 血管新生抑制作用を有するポリペプチド
CA2659990C (en) 2006-08-04 2016-03-22 Prolong Pharmaceuticals, Inc. Polyethylene glycol erythropoietin conjugates
US20100240578A1 (en) * 2006-08-18 2010-09-23 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Anti-h5n1 influenza activity of the antiviral protein cyanovirin
EP2068935B8 (en) 2006-09-15 2011-09-14 Creabilis Therapeutics s.r.l. Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
CN101143894A (zh) * 2007-06-22 2008-03-19 中国药科大学 高效抑制血管生成多肽及其物理化学修饰方法和应用
KR20170072365A (ko) 2007-12-27 2017-06-26 백스터 인터내셔널 인코포레이티드 생리학적으로 수용가능한 중합체 분자를 특이적으로 검출하기 위한 방법 및 조성물
US8637022B2 (en) 2008-06-30 2014-01-28 Esbatech, An Alcon Biomedical Research Unit Llc Functionalized polypeptides
CA2732508C (en) 2008-08-11 2016-03-15 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
NZ592688A (en) 2008-10-17 2012-12-21 Baxter Int Modified blood factors comprising a low degree of water soluble polymer
WO2010048184A2 (en) 2008-10-21 2010-04-29 Baxter International Inc. Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation)
EP2471915B1 (en) * 2009-08-28 2018-05-23 The Chemo-Sero-Therapeutic Research Institute Modified peptide vaccine derived from influenza m2
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US20140088021A1 (en) 2011-05-27 2014-03-27 Nektar Therapeutics Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
JP6255348B2 (ja) * 2011-12-19 2017-12-27 ジェンザイム・コーポレーション 甲状腺刺激ホルモン組成物
WO2019108656A1 (en) 2017-11-28 2019-06-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microbicidal composition
PL3731872T3 (pl) 2017-12-29 2022-03-21 F. Hoffmann-La Roche Ag Sposób dostarczania kompozycji pegylowanego białka
CN111727063A (zh) * 2017-12-29 2020-09-29 豪夫迈·罗氏有限公司 用于提供聚乙二醇化蛋白质组合物的方法
KR102523239B1 (ko) * 2017-12-29 2023-04-18 에프. 호프만-라 로슈 아게 페길화 단백질 조성물을 제공하기 위한 방법
CN116854785A (zh) * 2023-05-16 2023-10-10 青岛双元泰和药业有限公司 位点特异性修饰和标记的抗病毒肽氰病毒素n

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6780847B2 (en) * 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
WO2003066085A1 (en) 2002-02-07 2003-08-14 Delta Biotechnology Limited Albumin-fused anti-angiogenesis peptides
US7267941B2 (en) * 2002-12-19 2007-09-11 The Government of the United States of America as represented by The Secretary of The Department of Health and Human Services, The National Institutes of Health Cyanovirin variant-polymer conjugates

Also Published As

Publication number Publication date
EP1620129B1 (en) 2009-03-18
AU2003301122A1 (en) 2004-07-14
JP2006517400A (ja) 2006-07-27
US7547509B2 (en) 2009-06-16
DE60326774D1 (de) 2009-04-30
US20080015151A1 (en) 2008-01-17
KR20050084433A (ko) 2005-08-26
JP4903891B2 (ja) 2012-03-28
US7267941B2 (en) 2007-09-11
WO2004056852A2 (en) 2004-07-08
ATE425767T1 (de) 2009-04-15
AU2003301122B2 (en) 2009-11-26
CA2507904A1 (en) 2004-07-08
CA2507904C (en) 2014-12-02
JP2011050382A (ja) 2011-03-17
US20040258706A1 (en) 2004-12-23
EP1620129A2 (en) 2006-02-01
WO2004056852A3 (en) 2004-10-07
KR101145990B1 (ko) 2012-08-23

Similar Documents

Publication Publication Date Title
MXPA05006688A (es) Conjugados de polimero con una variante de cianovirina.
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
TW200510454A (en) Conjugates comprising human IL-18 and substitution mutants thereof
IL215981A0 (en) An antibody-drug conjugate, an article or manufacture and pharmaceutical compositions comprising thereof
BR0207378A (pt) Tratamento de câncer
MXPA03011935A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
BRPI0519046A2 (pt) composição de xampu
MX261407B (es) Metodos y composiciones de polimeros asociativos dilatables en alcali.
DE50010132D1 (de) Wasserlösliche oder wasserquellbare Polymerisate
WO2005058366A3 (en) Compositions comprising two different populations of polymer-active agent conjugates
SI1909843T1 (sl) Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju
WO2004069146A3 (en) L-dopa amide derivatives and uses thereof
PT1487498E (pt) Formulação tópica contendo um ciclofrutano, um veículo e um fármaco
DK1809661T3 (da) Humant interferon-beta-mutein
AU2158601A (en) Antiviral agent for use in treatment of cancer
DE60228544D1 (de) Triptolid-prodrugs zur krebstherapie
PL369148A1 (en) Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
CA99918S (en) Snow board
HRP20080569T3 (en) Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
EP2298074A3 (en) Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
WO2004108770A8 (en) Low odor chain transfer agents for controlled radical polymerization
ATE443453T1 (de) Tomatenprodukte
DE602004026747D1 (de) Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights